158 related articles for article (PubMed ID: 35338956)
1. ABCG2, SCN1A and CYP3A5 genes polymorphism and drug-resistant epilepsy in children: A case-control study.
Mousavi SF; Hasanpour K; Nazarzadeh M; Adli A; Bazghandi MS; Asadi A; Rad A; Gholami O
Seizure; 2022 Apr; 97():58-62. PubMed ID: 35338956
[TBL] [Abstract][Full Text] [Related]
2. The potential implication of SCN1A and CYP3A5 genetic variants on antiepileptic drug resistance among Egyptian epileptic children.
Abo El Fotoh WM; Abd El Naby SA; Habib MS; ALrefai AA; Kasemy ZA
Seizure; 2016 Oct; 41():75-80. PubMed ID: 27498208
[TBL] [Abstract][Full Text] [Related]
3. Association between Genetic Polymorphism of
Tang HX; Ho MD; Vu NP; Cao HV; Ngo VA; Nguyen VT; Nguyen TD; Nguyen TD
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674283
[No Abstract] [Full Text] [Related]
4. Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis.
Zhao GX; Zhang Z; Cai WK; Shen ML; Wang P; He GH
Epilepsy Res; 2021 Jul; 173():106615. PubMed ID: 33756436
[TBL] [Abstract][Full Text] [Related]
5. Association between SCN1A gene polymorphisms and drug resistant epilepsy in pediatric patients.
Margari L; Legrottaglie AR; Vincenti A; Coppola G; Operto FF; Buttiglione M; Cassano A; Bartolomeo N; Mariggiò MA
Seizure; 2018 Feb; 55():30-35. PubMed ID: 29353705
[TBL] [Abstract][Full Text] [Related]
6. Single-Base Gene Variants in
Buainain RP; Sodré AR; Dos Santos JS; Takazaki KAG; Queiroz LS; de Oliveira CTP; de Aguiar PHP; Marson FAL; Ortega MM
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892194
[TBL] [Abstract][Full Text] [Related]
7. Effects of UGT2B7, SCN1A and CYP3A4 on the therapeutic response of sodium valproate treatment in children with generalized seizures.
Feng W; Mei S; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
Seizure; 2018 May; 58():96-100. PubMed ID: 29679912
[TBL] [Abstract][Full Text] [Related]
8. The association of SCN1A p.Thr1067Ala polymorphism with epilepsy risk and the response to antiepileptic drugs in Slovenian children and adolescents with epilepsy.
Bertok S; Dolžan V; Goričar K; Podkrajšek KT; Battelino T; Rener-Primec Z
Seizure; 2017 Oct; 51():9-13. PubMed ID: 28753467
[TBL] [Abstract][Full Text] [Related]
9. Influence of genetic polymorphisms on imatinib concentration and therapeutic response in patients with chronic-phase chronic myeloid leukemia.
Cheng F; Cui Z; Li Q; Chen S; Li W; Zhang Y
Int Immunopharmacol; 2024 May; 133():112090. PubMed ID: 38640718
[TBL] [Abstract][Full Text] [Related]
10. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.
Shi L; Zhu M; Li H; Wen Z; Chen X; Luo J; Lin C; Zhang Z
Eur J Clin Pharmacol; 2019 May; 75(5):655-663. PubMed ID: 30693367
[TBL] [Abstract][Full Text] [Related]
11. Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children.
Liu M; Mao J; Xu H; Wang J; Zhao P; Xu Q; Du Z
Epilepsy Res; 2020 Dec; 168():106485. PubMed ID: 33096315
[TBL] [Abstract][Full Text] [Related]
12. SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.
Haerian BS; Baum L; Kwan P; Tan HJ; Raymond AA; Mohamed Z
Pharmacogenomics; 2013 Jul; 14(10):1153-66. PubMed ID: 23859570
[TBL] [Abstract][Full Text] [Related]
13. Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady-state disposition of lamotrigine in adults with epilepsy.
Klarica Domjanović I; Lovrić M; Trkulja V; Petelin-Gadže Ž; Ganoci L; Čajić I; Božina N
Br J Clin Pharmacol; 2018 Sep; 84(9):2106-2119. PubMed ID: 29791014
[TBL] [Abstract][Full Text] [Related]
14. Association between SCN1A polymorphism and carbamazepine responsiveness in epilepsy: A meta-analysis.
Zhang X; Liu J; Ye J
Epilepsy Res; 2021 Oct; 176():106627. PubMed ID: 34218210
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of the sodium voltage-gated channel, alpha subunit 1 (SCN1A -A3184G) gene among children with non-lesional epilepsy: a case-control study.
Ghazala E; Shahin DA; Wahba Y
Ital J Pediatr; 2022 Sep; 48(1):157. PubMed ID: 36056404
[TBL] [Abstract][Full Text] [Related]
16. ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients.
Zhang ML; Chen XL; Bai ZF; Zhao X; Li WX; Wang XY; Zhang H; Chen XF; Zhang SQ; Tang JF; Xiao XH; Zhao YL
Gene; 2021 Dec; 805():145907. PubMed ID: 34411648
[TBL] [Abstract][Full Text] [Related]
17. SCN1A Polymorphisms and Haplotypes Are Associated With Valproic Acid Treatment Outcomes in Chinese Children With Epilepsy.
Zhu J; Lu J; Shen X; He Y; Xia H; Li W; Guo H; Zhang J; Fan X
Pediatr Neurol; 2023 Sep; 146():55-64. PubMed ID: 37451178
[TBL] [Abstract][Full Text] [Related]
18. Genetic Analysis of Sodium Channel Genes in Pediatric Epilepsy Patients of Pakistan.
Ashfaq A; Saleem T; Sheikh N; Maqbool H
Genet Res (Camb); 2022; 2022():1168703. PubMed ID: 35136380
[TBL] [Abstract][Full Text] [Related]
19. Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.
Ma CL; Wu XY; Zheng J; Wu ZY; Hong Z; Zhong MK
Pharmacogenomics; 2014 Jul; 15(10):1323-36. PubMed ID: 25155934
[TBL] [Abstract][Full Text] [Related]
20. Association between two SCN1A polymorphisms and resistance to sodium channel blocking AEDs: a meta-analysis.
Bao Y; Liu X; Xiao Z
Neurol Sci; 2018 Jun; 39(6):1065-1072. PubMed ID: 29582177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
